Buy HUMULIN M 70/30 (INSULIN, INSULIN ISOPHANE) Online

Description

Summary Information: HUMULIN M 70/30 is a premixed insulin suspension for injection, combining two types of insulin: regular insulin and insulin isophane (NPH insulin). Each pen contains a fixed ratio of 70% NPH insulin and 30% regular insulin. This combination provides both immediate and intermediate-acting insulin effects, making it suitable for managing blood sugar levels in people with diabetes mellitus.

Product Composition: HUMULIN M 70/30 contains two types of insulin:

1. Regular Insulin: This component provides a rapid onset of action, helping to lower blood sugar levels quickly after injection.
2. Insulin Isophane (NPH Insulin): This component has an intermediate duration of action, providing a sustained lowering of blood sugar levels over a longer period.

The combination of these insulins in HUMULIN M 70/30 allows for both immediate and extended blood sugar control throughout the day.

Manufacturer: HUMULIN M 70/30 is manufactured by Lilly, a leading pharmaceutical company known for its expertise in diabetes care and insulin therapy. Lilly ensures product quality, safety, and compliance with regulatory standards in the production of HUMULIN M 70/30.

Package: HUMULIN M 70/30 is typically supplied in pens containing a total volume of insulin, measured in International Units (IU). Each pen may contain a different volume, such as 3 mL or 10 mL, depending on the manufacturer’s specifications. The packaging includes information such as the expiration date, lot number, and manufacturer details.

Usage Instructions: HUMULIN M 70/30 pens are designed for subcutaneous injection and are intended for use by individuals with diabetes who require insulin therapy. The dosage and administration schedule should be determined by a healthcare professional based on factors such as the patient’s blood sugar levels, mealtime insulin requirements, and insulin sensitivity. Patients should carefully follow the instructions provided by their healthcare provider for proper injection technique and dosage adjustment.

Benefits:

• Blood Sugar Control: HUMULIN M 70/30 provides both immediate and extended blood sugar control throughout the day, helping to manage hyperglycemia in people with diabetes mellitus.
• Convenient Administration: The prefilled pens offer a convenient and easy-to-use method for insulin delivery, allowing for accurate dosing and reduced risk of dosing errors.
• Flexible Dosing: HUMULIN M 70/30 pens allow for flexible dosing adjustments to accommodate individual insulin requirements and fluctuations in blood sugar levels.
• Improved Quality of Life: By helping to stabilize blood sugar levels, HUMULIN M 70/30 contributes to improved glycemic control, which can reduce the risk of long-term complications and enhance overall well-being in individuals with diabetes.

It is important for patients using HUMULIN M 70/30 to receive regular monitoring and guidance from their healthcare provider to optimize insulin therapy, prevent hypoglycemia, and achieve glycemic targets. Proper education on insulin administration, blood glucose monitoring, and lifestyle management is essential for successful diabetes management.